drugset / Trial / NCT02574091
Icotinib Hydrochloride Cream in Healthy Adults and Psoriasis Patients
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a phase I study to evaluate the safety, tolerability and pharmacokinetics of Icotinib Hydrochloride Cream in healthy adults and patients with mild to moderate psoriasis.
Timeline
- Start
- 2015-11-26
- Primary completion
- 2017-02-19
- Completion
- 2017-02-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Icotinib | Small molecule | 1 % | Topical |
| Subject | Icotinib | Small molecule | 2 % | Topical |